Djamel Lebeche

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

High Throughput Sequencing

Cardiovascular Risk Factors

Hypertrophic Cardiomyopathy

Top Venues

European heart journal

Cardiovascular drugs and therapy

Science advances

Journal of cardiovascular development and disease

This page only lists publications with an associated author ORCID identifier.

Publications

Abdul Majid, Fasilat Oluwakemi Hassan, Md Monirul Hoque, Joy Olaoluwa Gbadegoye, Djamel Lebeche
Bioactive Compounds and Cardiac Fibrosis: Current Insight and Future Prospect. Journal of cardiovascular development and disease 10 (7) (2023)
Qingqing Gu, Buyan-Ochir Orgil, Akhilesh Kumar Bajpai, Yufeng Chen, David George Ashbrook, Athena S Davenport, Jeffrey A Towbin, Djamel Lebeche, Enkhsaikhan Purevjav, Hongzhuan Sheng, Lu Lu
Expression Levels of the Tnni3k Gene in the Heart Are Highly Associated with Cardiac and Glucose Metabolism-Related Phenotypes and Functional Pathways. International journal of molecular sciences 24 (16) (2023)
Xinjiang Cai, Matthew A Allison, Bharath Ambale-Venkatesh, Neal W Jorgensen, Joao A C Lima, Evan D Muse, Robyn L McClelland, Steven Shea, Djamel Lebeche
Resistin and risks of incident heart failure subtypes and cardiac fibrosis: the Multi-Ethnic Study of Atherosclerosis. ESC heart failure 9 (5) (2022)
Nazha Hamdani, Sarah Costantino, Andreas Mügge, Djamel Lebeche, Carsten Tschöpe, Thomas Thum, Francesco Paneni
Leveraging clinical epigenetics in heart failure with preserved ejection fraction: a call for individualized therapies. European heart journal 42 (20) (2022)
Nazha Hamdani, Sarah Costantino, Andreas Mügge, Djamel Lebeche, Carsten Tschöpe, Thomas Thum, Francesco Paneni
Leveraging clinical epigenetics in heart failure with preserved ejection fraction: a call for individualized therapies. European heart journal 42 (20) (2021)
Perundurai S Dhandapany, Soojeong Kang, Deepak K Kashyap, Raksha Rajagopal, Nagalingam R Sundaresan, Rajvir Singh, Kumarasamy Thangaraj, Shilpa Jayaprakash, Cholenahally N Manjunath, Jayaprakash Shenthar, Djamel Lebeche
Adiponectin receptor 1 variants contribute to hypertrophic cardiomyopathy that can be reversed by rapamycin. Science advances 7 (2) (2021)
Nadjib Hammoudi, Dongtak Jeong, Rajvir Singh, Ahmed Farhat, Michel Komajda, Eric Mayoux, Roger Hajjar, Djamel Lebeche
Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes. Cardiovascular drugs and therapy 31 (3) (2018)
Rajvir Singh, Pedro Moreno, Roger J Hajjar, Djamel Lebeche
A role for calcium in resistin transcriptional activation in diabetic hearts. Scientific reports 8 (1) (2018)